17-78971688-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000262776.8(LGALS3BP):āc.1646A>Cā(p.Asp549Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,613,750 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000262776.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LGALS3BP | NM_005567.4 | c.1646A>C | p.Asp549Ala | missense_variant | 6/6 | ENST00000262776.8 | NP_005558.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS3BP | ENST00000262776.8 | c.1646A>C | p.Asp549Ala | missense_variant | 6/6 | 1 | NM_005567.4 | ENSP00000262776 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000625 AC: 95AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000457 AC: 115AN: 251380Hom.: 0 AF XY: 0.000493 AC XY: 67AN XY: 135904
GnomAD4 exome AF: 0.00130 AC: 1897AN: 1461632Hom.: 1 Cov.: 32 AF XY: 0.00126 AC XY: 916AN XY: 727134
GnomAD4 genome AF: 0.000625 AC: 95AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.000552 AC XY: 41AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.1646A>C (p.D549A) alteration is located in exon 6 (coding exon 5) of the LGALS3BP gene. This alteration results from a A to C substitution at nucleotide position 1646, causing the aspartic acid (D) at amino acid position 549 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at